1 results match your criteria: "The R. W. Johnson Pharmaceutical Institute[Affiliation]"
Bioorg Med Chem
June 2000
Drug Discovery Division, The R. W. Johnson Pharmaceutical Institute, Spring House, PA 19447, USA.
The neuropeptide galanin modulates several physiological functions such as cognition, learning, feeding behavior, and depression, probably via the galanin 1 receptor (GAL-R1). Using an HTS assay based on 125I-human galanin binding to the human galanin-1 receptor (hGAL-R1), we discovered a series of 1,4-dithiin and dithiipine-1,1,4,4-tetroxides that exhibited binding affinity IC50's to hGAL-R1 ranging from 190 to 2700 nM. Two of the dithiepin analogues, 7 and 23, behaved pharmacologically as hGAL-R1 antagonists in secondary assays involving adenylate cyclase activity and GTP binding to G-proteins.
View Article and Find Full Text PDF